Skip to main content
Premium Trial:

Request an Annual Quote

SFAz Awards Biodesign Institute $376K for Informatics, Genetic Imaging Technology

NEW YORK (GenomeWeb News) - The Biodesign Institute at Arizona State University said Friday it has received two research awards totaling $376,000 from the Science Foundation of Arizona to expand a bioinformatics database and to develop its genetic imaging technology.
Sudhir Kumar of the Biodesign Center for Evolutionary Functional Genomics received $142,000 to develop a database called the TimeTree, which is “a relational database of life on Earth that is easy to use for researchers, the public and K-12 students,” the institute said.
The institute said Neal Woodbury, director of the Biodesign Center for BioOptical Nanotechnology, received $234,000 to develop nanoscale techniques and imaging technologies to study gene regulatory networks of interest to biomedical research.
Biodesign Institute spokesman Joe Caspermeyer said in an e-mail that the institute is currently “ramping up our capabilities” in personalized medicine and bioinformatics, as well as other areas including convergence biology, public health and the environment.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.